GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
51 hedge funds and large institutions have $10.3M invested in Aevi Genomic Medicine Inc in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
84% less call options, than puts
Call options by funds: $13K | Put options by funds: $82K
Holders
51
Holding in Top 10
–
Calls
$13K
Puts
$82K
Top Buyers
| 1 | +$1.33M | |
| 2 | +$241K | |
| 3 | +$165K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$149K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$131K |
Top Sellers
| 1 | -$1.99M | |
| 2 | -$1.7M | |
| 3 | -$753K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$450K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$349K |